a developer of cancer treatments
Industry Biotechnology
A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with ACLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then ACLX could also see price increases.
Ticker / NAME | Correlation To AUTL | 1D Price Change % | ||
---|---|---|---|---|
AUTL | 100% | -2.04% | ||
ACLX - AUTL | 42% Loosely correlated | -3.81% | ||
ALLO - AUTL | 35% Loosely correlated | -4.56% | ||
BCAB - AUTL | 33% Poorly correlated | +3.39% | ||
VRDN - AUTL | 32% Poorly correlated | -1.43% | ||
ZYME - AUTL | 32% Poorly correlated | -1.79% | ||
More |
Ticker / NAME | Correlation To AUTL | 1D Price Change % |
---|---|---|
AUTL | 100% | -2.04% |
cancer theme (87 stocks) | 36% Loosely correlated | +0.89% |
drugs theme (265 stocks) | 30% Poorly correlated | +5.37% |
biotechnology theme (248 stocks) | 27% Poorly correlated | +5.56% |
europe theme (180 stocks) | 23% Poorly correlated | +0.17% |